Patients with Krabbe disease, a genetic demyelinating syndrome caused by deficiency of galactosylceramidase and the resulting accumulation of galactosyl-sphingolipids, develop signs of a dying-back axonopathy compounded by a deficiency of large-caliber axons. Here, we show that axonal caliber in Twitcher mice, an animal model for Krabbe disease, is impaired in peripheral axons and is accompanied by a progressive reduction in the abundance and phosphorylation of the three neurofilament (NF) subunits. These changes correlate with an increase in the density of NFs per cross-sectional area in numerous mutant peripheral axons and abnormal increases in the activity of two serine/threonine phosphatases (PP1 and PP2A) in mutant tissue. Similarly, acutely isolated mutant cortical neurons show abnormal phosphorylation of NFs. Psychosine, the neurotoxin accumulated in Krabbe disease, was sufficient to induce abnormal dephosphorylation of NF subunits in a normal motor neuron cell line as well as in acutely isolated normal cortical neurons. This in vitro effect was mediated by PP1 and PP2A, which specifically dephosphorylated NFs. These results demonstrate that the reduced caliber observed in some axons in Krabbe disease involves abnormal dephosphorylation of NFs. We propose that a psychosine-driven pathogenic mechanism through deregulated phosphotransferase activities may be involved in this process.
Introduction
Krabbe disease, a leukodystrophy caused by the deficiency of galactosyl-ceramidase (GALC) and the accumulation of the lipidraft-associated neurotoxin psychosine (Aicardi, 1993; Igisu and Suzuki, 1984; Suzuki, 1998; Wenger et al., 2000; White et al., 2009 White et al., , 2010 , is characterized by central and peripheral demyelination. The disease involves the activation of resident microglia and the continuous infiltration of macrophages, which become multinucleated globoid cells (Kanazawa et al., 2000; Wu et al., 2000) . Affected patients are primarily infants, who die within months after diagnosis. Albeit not a cure, cell therapy with hematopoietic precursors (bone marrow-or cord blood-derived cells) has proven to extend patients' survival, especially when performed within weeks after birth. Despite amelioration in some clinical hallmarks, motor and cognitive deficits in treated patients remain largely uncorrected (Eglitis and Mezey, 1997; Escolar et al., 2005; Galbiati et al., 2009; Kondo et al., 1988; Krivit et al., 1995) .
One hallmark of Krabbe disease is the rapid deterioration of nerve conduction, which has been historically related with the loss of myelin (Dolcetta et al., 2005; Toyoshima et al., 1986) . Interestingly, earlier reports indicated lower numbers of large-caliber axons in the mutant nerves (Hogan et al., 1969; Jacobs et al., 1982; Martin et al., 1974; Schlaepfer and Prensky, 1972) , a largely unaddressed defect that may contribute to the compromised nerve conduction observed in Krabbe patients and to the limited neuroprotection observed in most of treated patients. We recently found evidence of a peripheral neuropathy in the Twitcher mouse, the natural murine model of this disease (Castelvetri et al., 2011; Smith et al., 2011) . Interestingly, axonal damage started well before that of mutant neurons, which was minimal until the final stage of the disease when nerves were severely demyelinated. These observations raise the possibility that mechanisms controlling the maturation and stability of the axonal compartment (cytoskeletal components, axonal transport) are dysfunctional very early in the mutant mouse.
Expansion of the axonal cytoskeletal diameter is highly influenced by the content and phosphorylation of several neurofilaments (NF) subunits. NFs are intermediate components of the neuron cytoskeleton which are comprised of~60 kDa (NF-L),~100 kDa (NF-M) and
